Your browser doesn't support javascript.
loading
Infliximab for vascular involvement in Behçet's syndrome.
Hatemi, Gulen; Tukek, Nur Beyza; Esatoglu, Sinem Nihal; Ozguler, Yesim; Taflan, Sitki Safa; Uygunoglu, Ugur; Melikoglu, Melike; Ugurlu, Serdal; Fresko, Izzet; Siva, Aksel; Kutlubay, Zekayi; Yurdakul, Sebahattin; Yazici, Hasan; Hamuryudan, Vedat.
  • Hatemi G; Division of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey; Behçet's Disease Research Center, Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Tukek NB; Department of Internal Medicine, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Esatoglu SN; Division of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey; Behçet's Disease Research Center, Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Ozguler Y; Division of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey; Behçet's Disease Research Center, Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Taflan SS; Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Uygunoglu U; Behçet's Disease Research Center, Istanbul University-Cerrahpasa, Istanbul, Turkey; Department of Neurology, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Melikoglu M; Division of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey; Behçet's Disease Research Center, Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Ugurlu S; Division of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Fresko I; Division of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey; Behçet's Disease Research Center, Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Siva A; Behçet's Disease Research Center, Istanbul University-Cerrahpasa, Istanbul, Turkey; Department of Neurology, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Kutlubay Z; Behçet's Disease Research Center, Istanbul University-Cerrahpasa, Istanbul, Turkey; Department of Dermatology, Cerrahpasa Medical Faculty Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Yurdakul S; Division of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Yazici H; Academic Hospital, Istanbul, Turkey.
  • Hamuryudan V; Division of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey; Behçet's Disease Research Center, Istanbul University-Cerrahpasa, Istanbul, Turkey. Electronic address: vhamuryudan@yahoo.com.
Clin Immunol ; 253: 109682, 2023 08.
Article en En | MEDLINE | ID: mdl-37385325
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Síndrome de Behçet Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans / Male Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Síndrome de Behçet Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans / Male Idioma: En Año: 2023 Tipo del documento: Article